News Image

Novavax to Participate in Upcoming September Conferences

Provided By PR Newswire

Last update: Sep 7, 2022

GAITHERSBURG, Md., Sept. 7, 2022 /PRNewswire/ -- Novavax, Inc. ( Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences. Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.

Read more at prnewswire.com

NOVAVAX INC

NASDAQ:NVAX (7/3/2025, 11:11:08 AM)

6.805

+0.04 (+0.67%)



Find more stocks in the Stock Screener

Follow ChartMill for more